Doctor Maria Tafelmeier
University Hospital Regensburg, Regensburg (Germany)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Sacubitril/valsartan for treatment of symptomatic non-obstructive hypertrophic cardiomyopathy: a randomised, controlled, phase II clinical trial (SILICOFCM)
Event: ESC Congress 2023
Topic: Hypertrophic Cardiomyopathy
Session: Contemporary management of hypertrophic cardiomyopathy
